ShopSpell

Targeted Therapies in Cancer Myth or Reality [Paperback]

$118.99     $169.99    30% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  1441925376
  • ISBN-10:  1441925376
  • ISBN-13:  9781441925374
  • ISBN-13:  9781441925374
  • Publisher:  Springer
  • Publisher:  Springer
  • Pages:  191
  • Pages:  191
  • Binding:  Paperback
  • Binding:  Paperback
  • Pub Date:  01-Feb-2010
  • Pub Date:  01-Feb-2010
  • SKU:  1441925376-11-SPRI
  • SKU:  1441925376-11-SPRI
  • Item ID: 100896339
  • List Price: $169.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Jul 16 to Jul 18
  • Notes: Brand New Book. Order Now.

Billions of dollars are spent every year on research into targeted therapies for cancer. Thats why its more than ever crucial for the thousands of scientists working in the field to keep right up to date with the cutting edge. This fascinating collection of material goes a long way to helping them do so, featuring as it does contributions to a crucial international meeting in Italy. The meeting provided a forum for scientists and clinicians working in cancer drug discovery and therapy to share their opinions and experiences. The text here offers readers an overview of diverse approaches, ranging from drug discovery to cellular therapy. Overall, the book addresses the key question of whether ultimately targeted therapy in cancer will be a myth or a reality.

This crucial text offers readers an overview of diverse approaches to targeted cancer therapies, ranging from drug discovery to cellular therapy. Overall, the book addresses the key question of whether ultimately targeted therapy in cancer will be a myth or a reality.

In September 2005 an International Meeting on Targeted Therapies in Cancer: Myth or Reality was held in Milan. This successful Meeting was intended to represent a forum for scientists and clinicians working in cancer drug discovery and therapy to share their reflections and experiences on how the paradigm shift from empiricism to molecular targeted therapies is contributing to the translation of basic knowledge into new therapies for cancer patients. This book collects the contributions given by scientists and clinicians, from Academia and Industry, who participated to this Meeting.

We hope that this book contributes to improve our approach to cancer drug discovery and, ultimately, to find new, more efficacious and better tolerated drugs for cancer patients. It provides an overview of diverse approaches ranging from drug discovery to cellular therapy. Although thislóŒ

Add Review